Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Partial Prostate Salvage High Dose Rate Brachytherapy [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating partial salvage high-dose-rate brachytherapy for recurrent prostate cancer, sponsored by the British Columbia Cancer A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Recurrent Prostate Cancer | NA | Status: RECRUITING